Loading...
XETR
RHK
Market cap1.06bUSD
Jul 09, Last price  
13.90EUR
1D
-0.71%
1Q
12.10%
Jan 2017
-45.83%
Name

Rhoen Klinikum AG

Chart & Performance

D1W1MN
XETR:RHK chart
P/E
26.99
P/S
0.48
EPS
0.51
Div Yield, %
0.72%
Shrs. gr., 5y
Rev. gr., 5y
7.31%
Revenues
1.94b
+21.31%
1,933,043,0002,024,754,0002,130,277,0002,320,089,0002,550,384,0002,629,148,0002,864,909,0003,013,835,0001,510,519,0001,108,189,0001,176,349,0001,211,077,0001,232,908,0001,303,898,0001,360,159,0001,402,010,0001,446,086,0001,734,725,0001,595,619,0001,935,720,000
Net income
34m
-20.48%
105,200,000106,292,000122,644,000131,652,000145,069,000156,114,00089,685,00086,648,0001,225,711,00085,381,00056,430,00035,150,00048,993,00043,277,0001,451,00028,295,00025,144,00038,712,00043,351,00034,471,000
CFO
65m
-49.45%
235,600,000182,000,000187,000,000212,500,000221,500,000236,200,000139,100,000210,400,00049,200,00070,200,000109,100,00080,300,00049,500,00047,300,000113,300,00097,500,00060,300,000109,000,000127,600,00064,500,000
Dividend
Jun 04, 20250.1 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.
IPO date
Nov 27, 1989
Employees
18,062
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT